Cross-Border Impact Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Omer Inan(Co-founder, Chief Scientific Officer)inAndrew Carek(Co-founder, Chief Technical Officer)inAmit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan, PhD(Co-founder, Chief Scientific Officer)inAndrew Carek, PhD(Co-founder, Chief Technical Officer)in
Co-investorsBayMed Venture PartnersBroadview VenturesLaerdal Million Lives FundOSF VenturesPortal InnovationsHatteras Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.